GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)
Without insurance, brand GLP-1s cost $149 to $499 a month direct from the makers: Foundayo and the Wegovy pill from $149, Zepbound from $299, and the Wegovy pen $199 for the first two low-dose fills, then $349.
If your commercial plan covers the drug, a savings card can bring it to $25. On Medicare, the GLP-1 Bridge charges $50 a month if you qualify.
By GLP-1 Picks, an independent comparison publication. Sources linked below. Our editorial policy.
Summarize this article with

In this article
- 01How Much Do GLP-1 Medications Cost Without Insurance?
- 02When did Zepbound’s vial prices change?
- 03How Much Do Telehealth GLP-1 Programs Cost?
- 04How Do GLP-1 Savings Cards Work?
- 05Does Insurance Cover GLP-1 Medications for Weight Loss?
- 06Does Medicare Cover GLP-1 Medications?
- 07Does Medicaid Cover GLP-1 Medications?
- 08Can You Use FSA or HSA for GLP-1 Medications?
GLP-1 medications cost between $25 and $1,350 a month, depending on how you pay. List prices run up to about $1,350.
With a manufacturer savings card and commercial insurance that covers the drug, eligible patients may pay $25/month for some brands, subject to program terms.
On Medicare, eligible patients can pay $50 per monthly supply through the separate GLP-1 Bridge program, not ordinary Part D. Its covered formulations and authorization rules apply; Medicare lists the requirements.
Where to start, by your situation:
- •Commercial insurance that covers Wegovy, Zepbound or Foundayo: use the maker's savings card. You may pay $25/mo if you are eligible and within the offer terms.
- •No insurance, lowest advertised cash price: Embody (compounded semaglutide from $79 on a selected plan) or Enhance MD (compounded semaglutide $212/mo on a 12-month plan, $249 month-to-month).
- •No insurance, brand-name pill: Foundayo at $149/mo (lowest dose) via LillyDirect.
- •No insurance, brand-name injection: LillyDirect ($299/mo Zepbound) or NovoCare Wegovy ($199/mo for the first two low-dose fills, then $349/mo at standard strengths or $399 HD).
- •No insurance, bundled compounded plan: Sprout Health (2025 FDA warning for misleading compounded-drug marketing) lists compounded semaglutide at $149 every 4 weeks or $1,188 paid every 12 months ($99 monthly equivalent), with medication, clinician review and shipping included (checked October 5, 2026). That price does not establish superior clinical care or expected weight loss.
- •Medicare: the GLP-1 Bridge program may cover eligible weight-management use at $50/mo.
Use our cost calculator to estimate your monthly spend, see all providers sorted by lowest price, or take the 60-second match quiz.
Below you'll find list prices, the makers' direct programs (LillyDirect, NovoCare), the Foundayo pill (see all oral GLP-1 pills compared), compounded telehealth programs, savings cards, and Medicare and Medicaid coverage.
Sources: CMS GLP-1 Bridge Demonstration, Zepbound savings card terms, Wegovy savings offer, Foundayo savings card.
Find a program that fits your budget
Before you choose a plan, check the medication, the form (shot or pill), what you pay up front and what it renews at.
See program costs and commitments →How Much Do GLP-1 Medications Cost Without Insurance?
Manufacturer list prices are reference prices, not a quote for what you pay at the pharmacy. Here is each medicine three ways:
| Medication | List Price | Self-Pay/Direct | With Insurance + Savings Card |
|---|---|---|---|
| Wegovy (injection) | ~$1,349/mo | $199/mo for up to two eligible 28-day 0.25/0.5mg home-delivery fills; then $349 standard / $399 HD (NovoCare) | As low as $25/mo, if eligible |
| Wegovy (oral pill) | ~$1,349/mo | From $149/mo (NovoCare, dose-dependent) | As low as $25/mo |
| Ozempic | $1,027.51/mo | $199/mo for up to two eligible 28-day 0.25/0.5mg home-delivery fills; then $349 at 0.25-1mg / $499 at 2mg (NovoCare multidose pen) | As low as $25/mo, if eligible |
| Zepbound | ~$1,086/mo | $299 to 449/mo (LillyDirect KwikPens/vials) | As low as $25/mo |
| Mounjaro | $1,112.16/mo | From $499/mo at every strength (LillyDirect single-dose pens) | As low as $25/mo, if eligible |
| Foundayo (orforglipron) | ~$649/mo | $149-349/mo (LillyDirect; dose and 45-day refill terms apply) | As low as $25/mo |
| Saxenda (brand) | $1,349.02 (manufacturer list price) | Ask a pharmacy for a current quote for your prescribed quantity | Plan-specific; confirm your cost with your insurer |
| Generic liraglutide (Teva) | ~$1,165/mo | Check GoodRx | Varies |
The $199 home-delivery introduction requires no previous injection fill of the same brand through NovoCare or NovoCare Legacy: Ozempic history for Ozempic, Wegovy history for Wegovy.
Each covers at most two 28-day 0.25 or 0.5 mg fills, with the prescription written and received by December 31, 2026, and shipped by January 31, 2027. One billed Ozempic month means one box containing one pen.
Confirm any separate prescribing or follow-up charges before comparing the total. See the NovoCare delivery terms.
NovoCare's former Saxenda savings program closed to new enrollment on June 30, 2023, and previously activated benefits ended on December 31, 2023, according to NovoCare's Saxenda page.
Insurance coverage and pharmacy coupons are separate. Ask a pharmacy to quote your prescribed quantity at your location, and confirm any separate prescribing or follow-up fees.
Novo Nordisk announced US list prices of $675/month for Wegovy, Ozempic and Rybelsus from January 1, 2027.
It describes reductions of about 50% for Wegovy and 35% for Ozempic. These are manufacturer list prices, or wholesale acquisition costs, not pharmacy quotes. Novo says the change does not affect direct-to-patient self-pay prices.
Insurance cost sharing and clinic fees remain separate. Saxenda is on a different track: Novo's Saxenda notice puts the last shipments to wholesalers in late January 2027.
That does not establish when a particular pharmacy will run out of stock. Ask your pharmacist about local availability before budgeting for a prescription.
See our Saxenda discontinuation and switching guide for which liraglutide products remain available.
When did Zepbound’s vial prices change?
Lilly announced lower single-dose vial prices on December 1, 2025.
Its December announcement compares the LillyDirect self-pay monthly amounts below; the earlier prices also match Lilly’s February 25, 2025 announcement.
The $299 starting quote in that announcement dates to 2025.
| Single-dose vial strength | Prior monthly amount reported by Lilly | New monthly amount announced December 1, 2025 |
|---|---|---|
| 2.5 mg | $349 | As low as $299 |
| 5 mg | $499 | $399 |
These are manufacturer-published monthly vial quotes, not a comparison of complete treatment bills. The announcements do not specify the historical pack size or every eligibility condition.
A valid prescription and applicable terms are required. The 2.5 mg strength is a starting dose, not a maintenance dose.
Use our Zepbound cost guide to compare current products, refill terms and any separate prescribing or supply costs.
Join the list for the GLP-1 Letter.
We re-verify every price on this site against the provider's own live page and check every program against the FDA warning letter database. Join the list and you will hear from us when that work turns up something worth an email. No promised schedule until we are actually keeping one. Unsubscribe anytime.
No affiliate spam. No retargeting pixels. Unsubscribe in one click.
How Much Do Telehealth GLP-1 Programs Cost?
Online telehealth providers often offer lower total costs by bundling consultation fees with medication, though what the bundle covers varies more than the headline suggests.
Confirm whether the quote includes the consultation, medication, shipping and any required membership. Here's a sample of what platforms charge:
| Platform | Advertised price and terms | What's Included |
|---|---|---|
| Strut Health | From $99/mo on auto-refill | Compounded semaglutide buccal lozenge, not an approved swallowed tablet; FDA warning #721448 concerns marketing claims |
| Enhance MD compounded plans | Plan-dependent; confirm total commitment and billing schedule | Compounded semaglutide or tirzepatide, combo therapy options |
| TrimRx | GLP-1: $149/mo on 12 months or $174 month-to-month | GLP-1 + GIP: $249/mo on 12 months or $279 month-to-month. Full payment and renewal unconfirmed; generic package terms are separate. 4.7/10 with active delivery-complaints and BBB alerts |
| Found | $264/mo | Brand or compounded options, behavior coaching, insurance accepted |
| Ro | Membership fee plus prescribed medication | Medicine, dose and payment route change the bill; see Ro membership and medication costs. Confirm included services and the full quote. |
| LillyDirect | $299 to $449/mo | Zepbound brand KwikPens/vials, direct from manufacturer |
| NovoCare Pharmacy | Wegovy pen at $199/mo for the first two low-dose fills, then $349/mo at standard strengths ($399 for HD); pill from $149/mo | Brand medication direct from Novo Nordisk; prescription required, dose-dependent |
Compare the payment due, not just the monthly equivalent. bmiMD advertises compounded semaglutide at $159 for one month or $1,428 for 12 months and tirzepatide at $249 for one month or $2,148 for 12 months.
The annual payments work out to $119/mo and $179/mo, respectively; they are not month-to-month rates. These public prices were checked September 26, 2026.
Confirm the prescribed product, payment schedule and full quote before enrolling. SnagRx's $69/mo compounded semaglutide offer is another prepaid equivalent: its published terms list $828 paid upfront for 12 months, versus $99 billed monthly.
Non-refundable consultation wording does not establish a separate consultation surcharge. Confirm your prescription-specific full bill before paying.
Our cheapest list ranks telehealth GLP-1 programs by price, cheapest first. You can also take the 60-second match quiz to find the best provider for your insurance, budget, and medication preference.
For tirzepatide specifically, see our cheapest tirzepatide page.
If you are pricing one platform in particular, our review breaks down how much Willow's GLP-1 program costs tier by tier, alongside its Trustpilot and BBB records.
The cheapest advertised rate is only worth taking if the company behind it checks out, which is why we publish the underlying verification separately: the Trimi reviews and legitimacy check lays out what we could and could not confirm about the company behind one of the lowest annual-prepay rates we track.
A provider that does not publish a complete price cannot be compared as if its headline fee covers everything. Ask for the medication, program and shipping total before starting a paid intake.
Can you multiply an advertised monthly price by 12?
Not without knowing what the price covers and when it repeats. These examples show three different price structures, not interchangeable treatments or a cheapest-provider ranking.
Compounded injections and dissolving tablets should not be treated as clinically equivalent.
| What is advertised | What it does not establish | What to ask before paying |
|---|---|---|
| SkinnyRx compounded semaglutide injection: $99 for the first month. | The first-month offer does not establish the renewal amount. Its subscription terms also allow renewal processing before the next period starts. | What is my next charge, on what date will it process, and does the full bill include every required fee? |
| Shed compounded semaglutide injection: $159/mo under its 12-month plan label. | The multi-month terms specify 48 weeks of medication for that plan. The month label alone does not establish the cost of a full calendar year's supply. | What is the full payment schedule, how much medication does it cover, and when and how much would I pay for treatment beyond those 48 weeks? |
| MangoRx Slim, a compounded semaglutide and vitamin B6 dissolving tablet: starting at $67/month, with the plan card saying billed monthly. | The general FAQ says optional auto-refills process every 25 days. That leaves the refill and charge schedule for a selected Slim plan unresolved, despite its monthly label. | Which charge and refill schedule applies to my Slim prescription, what quantity is included, and what are the payment due now and the next payment date and amount? |
Get a written quote naming the product and form, supplied quantity and duration, payment due now, next payment date and amount, and any mandatory extras. Confirm cancellation terms and state eligibility with the selected provider.
Until those inputs agree, leave the annual total unknown rather than multiplying an introductory price or guessing an extra charge.
What does a low medication price cost after membership?
Collective lists compounded semaglutide injections at $59/month and tirzepatide injections at $69/month, plus a required $199 annual membership after a 21-day membership trial. Medication is billed monthly. The trial does not include free medication.
- Three months: $376 for semaglutide or $406 for tirzepatide, including one annual membership.
- Twelve months: $907 or $1,027, respectively. These are medication-and-membership subtotals, not prepaid medication plans.
- Before paying: confirm any electronic-prescription technology fee, which the terms permit without listing an amount. The calculations above exclude it and assume medication prices stay unchanged.
This can suit a cash-pay patient who values flat medication pricing across doses and accepts an annual membership. It is not a brand-name Wegovy or Zepbound program. Compounded medicines are not FDA-approved; a clinician must determine whether treatment is appropriate.
See Collective's full pricing and cancellation terms, or compare Collective with MEDVi for the differences between injections, tablets and membership costs.
Check Collective eligibility and current pricing. We may earn a commission through this affiliate link.
How Do GLP-1 Savings Cards Work?
If you have commercial insurance, the makers' savings cards are the biggest way to cut your cost:
Novo Nordisk (Wegovy, Ozempic): if you have commercial insurance that covers your medication, savings cards can bring your copay down to $25 per fill, subject to eligibility and program terms.
For cash-pay patients, NovoCare listed the Wegovy pen at $199/month for the first two low-dose fills, then $349/month at standard strengths ($399 for HD) and oral pill from $149/month when checked August 7, 2026; a prescription is required and pricing is dose-dependent.
Novo's March 31 launch included separate multi-month Wegovy offers at $249 to $329/month for the injection and $249 to $289/month for the pill through participating partners.
Those dated launch terms should not be substituted for the current manufacturer-direct floor. Text SAVE to 83757 for a digital savings card.
Eli Lilly (Zepbound, Mounjaro, Foundayo): eligible commercially insured patients may qualify for copays as low as $25 per fill under each program's terms.
If insurance does not cover Zepbound, its savings-card price may be $499/month. LillyDirect lists self-pay Zepbound from $299 to $449/month depending on dose and refill terms.
For Foundayo, LillyDirect lists $149/month at 0.8 mg, $149 at 2.5 mg (promotion through December 31, 2026; regular $199), $199 at 5.5 mg (promotion through December 31, 2026; regular $299) or $299 at 9 mg, and $299 at 14.5 mg or 17.2 mg only when refilled within 45 days, otherwise $349.
Check the current Foundayo savings-card terms and the medication-specific expiration and eligibility rules before relying on a copay figure.
Commercial savings cards generally exclude Medicare, Medicaid and other government insurance. Cash-pay programs and patient-assistance programs have separate terms.
If you have Medicare, check whether your prescription belongs under ordinary Part D or the separate Bridge before comparing costs. Medicare explains the Bridge's limits.
Does Insurance Cover GLP-1 Medications for Weight Loss?
Insurance coverage for GLP-1s is getting more restrictive for weight loss in 2026, despite growing demand:
- •8.5% of commercially insured people (16+ million) have no GLP-1 coverage for weight loss at all
- •The number of people without Wegovy coverage specifically increased 42% vs 2025, over 41 million without access
- •Major insurers including BCBS, Cigna, and UnitedHealthcare implemented new restrictions as of January 2026, mostly limiting coverage to Type 2 diabetes only
- •Most insurers still cover Ozempic and Mounjaro for diabetes; the restrictions mainly hit weight-loss-only prescriptions
Does Medicare Cover GLP-1 Medications?
CMS launched the separate Medicare GLP-1 Bridge on July 1, 2026. It is not a change to ordinary Part D's weight-loss exclusion:
- •Beneficiary copay: $50 per approved monthly supply, with separate clinic fees possible
- •The $50 does not count toward Part D's deductible or out-of-pocket limit
- •Includes Foundayo tablets, Wegovy injection/tablets and Zepbound KwikPen, not Zepbound single-dose pens or vials
- •Eligible drug-plan enrollment, clinical criteria at treatment initiation, excluded diagnoses and prior Part D-paid GLP-1 use all matter
- •Clinical thresholds: BMI 35+, or BMI 30+/27+ with only the specific CMS-listed conditions; meeting a threshold does not establish approval
The Bridge is scheduled through December 31, 2027. CMS says the planned 2027 Part D launch of BALANCE is not proceeding; future Part D implementation is a possibility, not confirmed permanent coverage.
State Medicaid participation is a separate question. CMS's current Bridge timeline.
Does Medicaid Cover GLP-1 Medications?
As of January 2026, only 13 state Medicaid fee-for-service programs cover GLP-1s for obesity treatment, down from 16.
California, New Hampshire, Pennsylvania, and South Carolina recently eliminated coverage. Michigan added strict requirements including morbid obesity classification and documented failure of other interventions.
Do not treat a national program announcement as confirmation of your state's benefits. Check the current state drug policy and managed-care plan for the exact indication and formulation.
The CMS BALANCE page is the source for model participation updates, not a personal coverage decision.
Can You Use FSA or HSA for GLP-1 Medications?
Prescribed GLP-1 treatment may qualify for HSA or FSA payment, but a provider accepting the card does not establish eligibility for every medication, membership or extra charge. HealthEquity explains that eligibility and documentation depend on the expense and account rules.
Use our GLP-1 HSA/FSA payment checklist to request an itemized bill, check reimbursement requirements and confirm timing before prepaying.
Medical disclaimer: This article is general information, not medical advice. Talk to a licensed clinician before you start, stop or change any medication. Prices and rules can change after the date we checked them.
Affiliate disclosure: Some links in this article are affiliate links. If you join a program through one, we may earn a commission at no extra cost to you.
Featured GLP-1 option: Embody

from $49/mo at Embody (Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27). Check the full payment and renewal terms before you choose a plan.
This is a featured partner. We may earn a commission if you join. It never changes a score or a ranking.
Opens Embody's site. Partner link.
Medicare & GLP-1
Medicare GLP-1 Coverage Guide
On Medicare? From July 1, 2026, the Medicare GLP-1 Bridge sets a $50 monthly copay for Wegovy, Zepbound and Foundayo. Our guide explains who qualifies and what it covers.
Read the Medicare guide →Related Reading
Keep exploring this topic
Providers
Featured GLP-1 partners
Quick Links
Keep exploring
What the doctors say
Quotes from named doctors and medical bodies, each linked to where they said it. We did not ask for them, and they do not endorse any provider.
“Americans should be confident that the prescription drugs they take are safe. By strengthening oversight of imported APIs and cracking down on illegal drugs entering the U.S., we are taking aggressive action to protect consumers from poor-quality or dangerous GLP-1 drugs.”
“While compounding can play an appropriate role when used to meet the specific needs of an individual patient, the large-scale production and marketing of compounded versions of these medicines raises serious safety risks when products have not undergone the rigorous scientific and regulatory review required for FDA-approved therapies.”
“It's not just filling out a form online and then having some random healthcare provider sign off on it. There are concerns with some of these online programs that there's not a proper evaluation, there's not a baseline, and there's not proper supervision.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.



